Carl Torbjörn Bäckström
Director/Board Member chez DIAMYD MEDICAL AB
Fortune : 980 $ au 31/03/2024
Provenance du réseau au premier degré de Carl Torbjörn Bäckström
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Umea Universitet
21
| College/University | Other Consumer Services | 21 |
| Public Company | Pharmaceuticals: Major | 13 | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden.
4
| Private Company | Biotechnology | 4 |
Obstetrics & Gynecology, Inc.
 Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO.
1
| Private Company | Medical/Nursing Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Carl Torbjörn Bäckström via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ENSKILDA BANKEN | Major Banks | Director/Board Member | |
Bonnier AB
 Bonnier AB Publishing: NewspapersConsumer Services Bonnier AB provides publishing services and disseminates news, debate, and entertainment. It operates through television, newspapers, business and trade press, magazines, film, books, radio, and digital media. The company was founded in 1804 and is headquartered in Stockholm, Sweden. | Publishing: Newspapers | Chief Tech/Sci/R&D Officer | |
| VITEC SOFTWARE GROUP AB | Packaged Software | Founder Founder | |
AB Wilhelm Becker
 AB Wilhelm Becker Chemicals: SpecialtyProcess Industries AB Wilhelm Becker operates as a holding company with interests in chemical companies. It manufactures industrial coatings for metals and plastics, and products for surface treatment of wood. The company is headquartered in Hoganas, Sweden. | Chemicals: Specialty | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Filmstaden AB
 Filmstaden AB Movies/EntertainmentConsumer Services Filmstaden AB owns and operates theaters and cinemas. Its operation focuses on culture and entertainment events through cinemas and lounges. The company was founded on September 5, 1905 and is headquartered in Stockholm, Sweden. | Movies/Entertainment | Director/Board Member | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Graduate Degree Doctorate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Lunarstorm Sverige AB
 Lunarstorm Sverige AB Internet Software/ServicesTechnology Services Lunarstorm Sverige AB operates an online community. The private company is based in Stockholm, Sweden. | Internet Software/Services | Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Kabi Pharmacia | Corporate Officer/Principal | ||
Dagens Industri AB
 Dagens Industri AB Publishing: NewspapersConsumer Services Dagens Industri AB engages in online publishing. It offers stock exchange and financial information in tabloid format. The company was founded in 1976 and is headquartered in Stockholm, Sweden. | Publishing: Newspapers | Director/Board Member | |
Capitex AB
 Capitex AB Information Technology ServicesTechnology Services Capitex AB develops software for financial advisors in real estate, finance and insurance. The company was founded in 1981 and is headquartered in Kalmar, Sweden. | Information Technology Services | Director/Board Member Chairman | |
Novozymes Biopharma Sweden AB
 Novozymes Biopharma Sweden AB BiotechnologyHealth Technology Part of Repligen Corp., Novozymes Biopharma Sweden AB operates as a contract manufacturer of biological products. The private company is based in Lund, Sweden. The CEO of the Swedish company is Harald Skogman. Novozymes Biopharma Sweden was acquired by Repligen Corp. from Novozymes A/S on December 20, 2011 for $29.02 million. | Biotechnology | Corporate Officer/Principal | |
Biochromix AB
 Biochromix AB Medical SpecialtiesHealth Technology BioChromix AB manufactures diagnostic products. It is a company in the life science arena that develops and commercializes products for early stage diagnostics of Alzheimer's disease (AD) and identification of biomarkers associated to AD. The firm’s methods are based on their novel and patented Luminescent Conjugated Polymer (LCP) molecules. The company is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Public Communications Contact Founder | |
| KANCERA AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Trafikverket
 Trafikverket Other TransportationTransportation Trafikverket responsibles for the long-term planning of the transport system for road, rail, shipping, and aviation. It also handles construction, operation, and maintenance of state roads and railways. It also works for basic accessibility in the inter-regional public passenger transport by including procurement of traffic. Its goal is that there should be no fatalities or serious injuries in road traffic. The company was founded on April 2, 2010 and is headquartered in Borlange, Sweden. | Other Transportation | Chief Investment Officer Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| KD Incentive AB | Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| Stockholm Biotechbuilders Association | Director/Board Member | ||
| NANEXA AB | Medical Specialties | Corporate Officer/Principal | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
| NEXTCELL PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Pharmor AB | Chief Executive Officer | ||
| ZICCUM AB | Medical Specialties | Corporate Officer/Principal | |
| Isles of Wines AB | Chief Executive Officer | ||
| Bactaviva AB | Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
| AstraZeneca R & D Lund | Director/Board Member General Counsel |
Statistiques
Internationale
| Suède | 48 |
| Royaume-Uni | 2 |
| Danemark | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 5 |
| Technology Services | 5 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 271 |
| Corporate Officer/Principal | 76 |
| Chairman | 68 |
| Chief Executive Officer | 40 |
| Independent Dir/Board Member | 32 |
Relations les plus connectées
- Bourse
- Insiders
- Carl Torbjörn Bäckström
- Connexions Sociétés
